Search

Your search keyword '"Ma, Weijie"' showing total 24 results

Search Constraints

Start Over You searched for: Author "Ma, Weijie" Remove constraint Author: "Ma, Weijie" Publication Type Electronic Resources Remove constraint Publication Type: Electronic Resources
24 results on '"Ma, Weijie"'

Search Results

1. Dynamic evaluation of blood immune cells predictive of response to immune checkpoint inhibitors in NSCLC by multicolor spectrum flow cytometry.

2. Increasing cure rates of solid tumors by immune checkpoint inhibitors.

3. Labyrinthin Expression Is Associated with Poor Prognosis in Patients with Non-Small-Cell Lung Cancer.

4. Cancer neoantigens as potential targets for immunotherapy.

5. Emerging precision neoadjuvant systemic therapy for patients with resectable non-small cell lung cancer: current status and perspectives.

6. CrossFusion: Interleaving Cross-modal Complementation for Noise-resistant 3D Object Detection

7. Cancer neoantigens as potential targets for immunotherapy.

8. Small molecule tyrosine kinase inhibitors modulated blood immune cell counts in patients with oncogene-driven NSCLC.

9. Small molecule tyrosine kinase inhibitors modulated blood immune cell counts in patients with oncogene-driven NSCLC.

10. Small molecule tyrosine kinase inhibitors modulated blood immune cell counts in patients with oncogene-driven NSCLC.

11. Hospitalized cancer patients with comorbidities and low lymphocyte counts had poor clinical outcomes to immune checkpoint inhibitors.

12. Toward Clinically Assisted Colorectal Polyp Recognition via Structured Cross-modal Representation Consistency

13. Durable clinical response to the multidisciplinary management of neurosurgery, radiation and chemoimmunotherapy in a patient with PD-L1/PD-L2/JAK2 (PDJ)-amplified, refractory triple-negative breast cancer.

14. Targeting HER2 genomic alterations in non-small cell lung cancer.

15. Squamous Cell Transformation of Primary Lung Adenocarcinoma in a Patient With EML4-ALK Fusion Variant 5 Refractory to ALK Inhibitors.

18. Squamous Cell Transformation of Primary Lung Adenocarcinoma in a Patient With EML4-ALK Fusion Variant 5 Refractory to ALK Inhibitors.

19. Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy.

20. Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy.

21. Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors.

22. Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors.

23. Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report.

24. Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report.

Catalog

Books, media, physical & digital resources